What the stack actually looks like by tier
Pabau has won the premium medi-aesthetic segment in Singapore: it ships injection plotting, before/after photo workflows, consent management aligned to HSA expectations, and prescription management adaptable to HSA's therapeutic product register. Pricing per Consentz's 2026 Singapore market write-up runs S$300-750 monthly for typical clinic deployments; Zenoti enterprise sits at S$750-2,500+ for multi-location luxury operators. Cliniko's per-practitioner pricing starts at US$45/month and tops out at US$395/month for 26-200 practitioners, with SMS billed separately at roughly US$0.10/message.
Heidi Health's price reset matters. The Clinician plan moved from US$90/month annual to US$150/month annual in 2026, with a free tier capped at 10 Pro Actions/month. At that price, Heidi's value depends on whether multilingual capability is real for your patient mix — Mandarin/English in Singapore, Thai/English in Bangkok, Bahasa/English in Jakarta and KL. Heidi's own Series B documentation states it "supports more than 2 million consults each week in 110 languages from 116 countries"; Abridge, Suki AI and DAX Copilot remain US-English-weighted and enterprise-priced (DAX at ~US$600/provider/month, Abridge and Suki on custom enterprise pricing only).
The premium-versus-mass split
In Orchard Road Singapore, the stack we see most often: Pabau as practice management, Heidi for documentation, Consentz for consent workflows specifically because Pabau and Consentz both flag HSA-registered prescription products with batch traceability — material in a recall event. In Bangkok premium clinics (Bumrungrad-adjacent, Thonglor district), Pabau adoption is rising but the dominant pattern remains a custom-built EMR plus WhatsApp Business plus Fresha for booking. In Manila premium clinics (BGC, Makati Med corridor), the constraint is bandwidth and FDA documentation overhead — Cliniko is more common than Pabau because of price.
The mass-market tier — salons doing brow/lash, light injectables, single-room clinics — runs Fresha free across all six SEA markets. Fresha's marketplace dynamic is a double-edged sword: it drives bookings but commoditises price by surfacing nearby competitors in the same app. None of these tools — Pabau, Cliniko, Fresha — ship multi-step WhatsApp aftercare natively, which is the gap PostCare and others are filling.
What this means for new market entry
For a brand entering SEA distribution, the question is not "which EMR" but "which EMR cluster does your target clinic segment use." A premium injectable brand selling into Singapore and Bangkok aesthetic clinics is reaching a Pabau-Heidi-Consentz stack with PDPA-aware data flows. A mass-market supplement brand selling into salon-adjacent operators is reaching Fresha+WhatsApp. Reps walking into the wrong stack waste calls.